Compare NBY & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBY | GCTK |
|---|---|---|
| Founded | 2000 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.2M | 1.6M |
| IPO Year | 2007 | 2011 |
| Metric | NBY | GCTK |
|---|---|---|
| Price | $1.19 | $1.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 38.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 35.42 | ★ 17910.53 |
| EPS | 0.76 | ★ 30.09 |
| Revenue | $370,000.00 | ★ $589,462.00 |
| Revenue This Year | $23.91 | N/A |
| Revenue Next Year | $32.05 | N/A |
| P/E Ratio | $1.82 | ★ $0.05 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.43 | $0.09 |
| 52 Week High | $19.95 | $15.90 |
| Indicator | NBY | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 41.33 | 29.51 |
| Support Level | $0.99 | $0.11 |
| Resistance Level | $1.36 | $4.24 |
| Average True Range (ATR) | 0.26 | 0.12 |
| MACD | 0.21 | 0.08 |
| Stochastic Oscillator | 31.95 | 28.84 |
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.